Fulcrum Therapeutics Shares Are Trading Lower After HC Wainwright & Co and RBC Capital Downgraded the Company and Lowered Their Respective Price Targets on the Stock.
Fulcrum Therapeutics Shares Are Trading Lower After HC Wainwright & Co and RBC Capital Downgraded the Company and Lowered Their Respective Price Targets on the Stock.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.